| AJCC cancer staging manual DR Byrd, RK Brookland, MK Washington, JE Gershenwald, CC Compton, ... springer, 2017 | 10206 | 2017 |
| Comprehensive molecular characterization of gastric adenocarcinoma Cancer Genome Atlas Research Network Nature 513 (7517), 202, 2014 | 5583 | 2014 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 5003 | 2018 |
| Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction JS Macdonald, SR Smalley, J Benedetti, SA Hundahl, NC Estes, ... New England Journal of Medicine 345 (10), 725-730, 2001 | 4822 | 2001 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 3059 | 2018 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2826 | 2018 |
| Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 … E Van Cutsem, VM Moiseyenko, S Tjulandin, A Majlis, M Constenla, ... Journal of clinical oncology 24 (31), 4991-4997, 2006 | 2702 | 2006 |
| Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a … H Wilke, K Muro, E Van Cutsem, SC Oh, G Bodoky, Y Shimada, ... The lancet oncology 15 (11), 1224-1235, 2014 | 2653 | 2014 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2423 | 2018 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2271 | 2018 |
| First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised … YY Janjigian, K Shitara, M Moehler, M Garrido, P Salman, L Shen, ... The Lancet 398 (10294), 27-40, 2021 | 2186 | 2021 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1841 | 2018 |
| Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer DP Kelsen, R Ginsberg, TF Pajak, DG Sheahan, L Gunderson, J Mortimer, ... New England Journal of Medicine 339 (27), 1979-1984, 1998 | 1688 | 1998 |
| Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer RJ Kelly, JA Ajani, J Kuzdzal, T Zander, E Van Cutsem, G Piessen, ... New England Journal of Medicine 384 (13), 1191-1203, 2021 | 1361 | 2021 |
| Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology JA Ajani, TA D’Amico, DJ Bentrem, J Chao, D Cooke, C Corvera, P Das, ... Journal of the National Comprehensive Cancer Network 20 (2), 167-192, 2022 | 1145 | 2022 |
| Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection SR Smalley, JK Benedetti, DG Haller, SA Hundahl, NC Estes, JA Ajani, ... Journal of clinical oncology 30 (19), 2327-2333, 2012 | 1018 | 2012 |
| Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018 | 1012 | 2018 |
| Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer cell 33 (4), 676-689. e3, 2018 | 983 | 2018 |
| Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial JA Ajani, KA Winter, LL Gunderson, J Pedersen, AB Benson, CR Thomas, ... Jama 299 (16), 1914-1921, 2008 | 983 | 2008 |
| Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology JA Ajani, TA D'Amico, K Almhanna, DJ Bentrem, J Chao, P Das, ... Journal of the National Comprehensive Cancer Network 14 (10), 1286-1312, 2016 | 954 | 2016 |